view more →
410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.
view more →
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.
view more →
Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.
view more →
The company’s small-molecule therapies focus on cyclin-dependent kinases and CDKs. IPO in May 2017 (NASDAQ: GTHX).
view more →
The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.
view more →
Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023
view more →
Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.
